ANDA Submission and GDUFA Guidance

2 years ago Posted By : User Ref No: WURUR102456 0
  • Image
  • TypeWebinar
  • Image
  • Location Online Event
  • Price
  • Date 28-03-2022
Webinar Title
ANDA Submission and GDUFA Guidance
Event Type
Webinar
Webinar Date
28-03-2022
Location
Online Event
Organization Name / Organize By
Complianceonline
Organizing/Related Departments
Sales & marketing
Organization Type
Event Management Company
WebinarCategory
Both (Technical & Non Technical)
WebinarLevel
All (State/Province/Region, National & International)
Related Industries

Research/Science

Business Development

Medical/Healthcare/Hospital

Textiles/Garments/Accessories

Location
Online Event

An ANDA is an Abbreviated New Drug Application. This application is submitted to the FDA to seek approval to produce a U.S. generic drug from an existing patented approved drug. The ANDA is submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs. After approval, the applicant is able to produce and market the generic drug product.

Registration Fees
Not Mention
Registration Ways
Website
Address/Venue
Online Event  6201 America Center Drive Suite 240, San Jose, CA 95002, USA 
Contact

Date & Time

  • Date
    March 28 2022
  • Time
    10:00 AM - 01:00 PM

Venue/Address

  • Online Event
    6201 America Center Drive Suite 240, San Jose, CA 95002, USA